Brief: Karolinska Development Portfolio Co Secures Bridge Financing
Nov 20 (Reuters) - Karolinska Development AB KDEV.ST :
* SAID ON TUESDAY MODUS THERAPEUTICS SECURED BRIDGE
FINANCING OF
UP TO SEK 5 MLN FROM KAROLINSKA DEVELOPMENT
* FUNDING ENABLES MODUS TO INITIATE THE RECENTLY APPROVED
PHASE 2A
STUDY IN CHRONIC KIDNEY DISEASE
Source text for Workspace: urn:newsml:reuters.com:*:nGNE9kgNgJ
Further company coverage: KDEV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue